ARGENE-BIOSOFT is dedicated to medical research and special diagnosis. We propose new and inventive solutions to hospital laboratories carrying on centralised analysis, and we supply research institutions, medical diagnosis operators and diagnosis reagent manufacturers, with products such as : polyclonal and monoclonal antibodies, nuclear and oligonuclear probes, synthetic proteins and ultra refined peptides, microbial antigens as well as a full service for analysing and fragmenting DNA, synthetising and producing probes, antibodies and DNA fragments incorporating such materials
Diatec Monoclonals specialises in customised productions of antibodies, aiming to tailor customers' antibodies to their needs. Our long experience and competence in producing and processing antibodies, means that we are your best option for outsourcing production and conjugations of antibodies. Diatec Monoclonals also analyse and quality assure customers' valuable clones and make stock cell banks for production and storage in our liquid nitrogen tanks. In addition to antibodies against the most common human CD markers, human IgE and anti-human C5b-9 are also included in our product portfolio.
Leinco Technologies was founded in 1992 as a specialty manufacturer of early discovery research products and provider of custom biotechnology development and manufacturing services. Our leading edge products and services are used in life science research, biotechnology, pharmaceutical development and the diagnosis of diseases. We provide products, services and world-class technical support to a broad range of customers worldwide. Our customers work in academic and government research institutions, hospitals, biotechnology, pharmaceutical and diagnostic companies.
http://www.trilliumtherapeutics.com
Trillium Therapeutics Inc. (TTI), a research-driven biopharmaceutical company with a strong immunology focus, specializes in the discovery and development of innovative therapies for the treatment of immune-mediated disorders. The company's therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant and harmful immune responses, such as autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases. TTI is primarily involved in the development of protein therapeutics, such as monoclonal antibodies, secreted proteins and peptides. The company's business model is to identify therapeutic candidates that have shown promise in animal models and to rapidly advance these into clinical testing. TTI is concentrating its efforts on preclinical and early clinical drug development, with the primary objective of demonstrating safety and efficacy in man. TTI has chosen to establish development partnerships for some of its projects at a preclinical stage, and anticipates advancing several others into clinical development on its own. TTI has three scientific programs containing six product opportunities at various stages of preclinical testing. One program focuses on the immunoregulatory protein CD200 and its receptor, a second is based upon the activating Fc receptor FcgRIIa (CD32a) and the third involves the use of a growth factor in the treatment of gastrointestinal inflammation and damage. The company has numerous research collaborations that provide access to world-class laboratories and a series of discovery projects.
Sigma-Genosys is a leading supplier of synthetic DNA (oligonucleotides), custom peptides and peptide antisera, and gene arrays to the global life science community. Based in The Woodlands, TX, Sigma-Genosys is committed to the success of our customers, employees and shareholders through leadership in Life Science, High Technology, and Science. We offer a highly motivational and rewarding working environment with attractive salary, benefits, retirement, relocation and incentive packages including tuition reimbursement. Sigma-Genosys fosters the growths of employees in a culture of respect and dignity with ample opportunity for career advancement.
QSV Biologics, Ltd. is a North American based cGMP biologics contract manufacturer providing mammalian cell culture, microbial fermentation and purification services for the production of protein therapeutics, monoclonal antibodies, vaccines and diagnostics. Our facility has a 10 year track record and is licensed for cGMP manufacture of pre-clinical, clinical and commercial supply. QSV recently underwent a comprehensive GMP compliance audit by Health Canada's Health Products and Food Branch Inspectorate (HPFBI) and was found to be compliant with all applicable regulations and guidelines. QSV's market consists of Canadian, U.S., Australian, Asian and European biotechnology firms with protein therapeutics in development. As a dedicated biopharmaceutical contract manufacturer, QSV provides the following services: cGMP Microbial Fermentation Microbial Process Development Upstream and Downstream Mammalian Cell Culture Process Development Upstream and Downstream cGMP Cell Bank Development & Storage Analytical Development Process & Analytical Validation Process Scale Up cGMP Document Services Technology Transfer Quality is your first consideration when selecting a contract manufacturer. Quality is our first priority! More information can be obtained by contacting: Richard Hetrick Business Development Phone: (484) 678 - 4820 Phone: (780) 438 - 7143 Fax: (610) 873 - 8453 Email: rhetrick@qsvbiologics.com
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory